← Back
Data updated: Mar 29, 2026
GEN ILAC
OncologyGastroenterology
Generics
GEN ILAC is a generic drug manufacturer focused on Oncology, Gastroenterology.
2025
Since
1
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 50%
1 drugs
Gastroenterology 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2025-08-28
- Latest
- 2025-08-28
- Applications
- 1